Invitae (NYSE: NVTA), a leading medical genetics company, today announced it has entered into a definitive agreement to acquire Ciitizen, a patient-centric consumer health tech company. Backed by a16z, Section 32 and Verily, Ciitizen is working to build a global platform to help patients collect, organize, store and share their medical records digitally. The acquisition would enhance Invitae's platform by providing patients an easy-to-use, centralized hub for their genomic and clinical information, which together comprise a powerful dataset with the potential to drive research and improve healthcare decision making.
Search
Recent Posts
See AllBy: Catherine Shu Legacy healthcare software systems are often complicated and cumbersome for providers to use, leading to less time with patients. That’s why Regard (formerly HealthTensor) developed
By: Richard Gawel In 2020, guidelines changed to encourage parents and caregivers to introduce peanut and egg to infants aged 4 months to 6 months to help prevent food allergies. Yet many parents stil
Medicare Bundles See 55-70% Cost Savings with Luna's In-Home Outpatient PT Program, New Study Reveal
Luna announced the results of a retrospective analysis which demonstrated significant financial savings for those choosing in-home outpatient physical therapy (PT) compared to traditional home health
